Product-based investments in late-stage clinical and commercial biopharmaceutical programs

PRODUCT FINANCE™ investing was developed by NovaQuest’s founders over 20 years ago as a tailored capital solution to support pivotal clinical trials and product launches, typically deployed through a nondilutive and noncontrolling investment structure. We are passionate about funding innovation in biopharmaceutical development. Better solutions for patients equal a healthier, more productive society.

Investment Criteria

NovaQuest works directly with companies to help make their R&D pipelines a reality for patients and caregivers around the globe. We look to partner with seasoned teams of pharma operators focused on long term value creation, which have promising late-stage assets and unmet capital needs.


We are open to collaboration with investment bankers, advisors, and intermediaries. Contact with opportunities and inquiries.


Structure finance investments of $30-100 million of non-dilutive capital for the development and commercialization of late-stage pharmaceutical products.

Value-added Capital

We believe in value creation through partnership. NovaQuest provides capital, but also offers pharma operators the benefit of 300+ years of collective interdisciplinary biopharma experience to help realize value in their pipelines and grow their companies.

*As of December 31, 2021

See Our Product Finance Investments

Learn More